Bausch Health
BHC
S$8.86
Share price
1.77%
Change (1 day)
10.89%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Bausch Health (BHC) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : S$34.28 Billion
According to Bausch Health 's latest financial reports the company's total liabilities are S$34.28 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Bausch Health - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | S$36.48 B | 0.72% |
| 2023-12-31 | S$36.22 B | 6.29% |
| 2022-12-31 | S$34.08 B | -13.76% |
| 2021-12-31 | S$39.52 B | -2.35% |
| 2020-12-31 | S$40.47 B | -8.27% |
| 2019-12-31 | S$44.12 B | 8.83% |
| 2018-12-31 | S$40.54 B | -3.93% |
| 2017-12-31 | S$42.20 B | -27.59% |
| 2016-12-31 | S$58.28 B | -4.03% |
| 2015-12-31 | S$60.73 B | 119.89% |
| 2014-12-31 | S$27.61 B | -4.12% |
| 2013-12-31 | S$28.80 B | 65.51% |
| 2012-12-31 | S$17.40 B | 46.43% |
| 2011-12-31 | S$11.88 B | 56.83% |
| 2010-12-31 | S$7.57 B | 665.87% |
| 2009-12-31 | S$0.98 B | 64% |
| 2008-12-31 | S$0.60 B | -13.41% |
| 2007-12-31 | S$0.69 B | -48.95% |
| 2006-12-31 | S$1.36 B | 1.41% |
| 2005-12-31 | S$1.34 B | 25.56% |
| 2004-12-31 | S$1.07 B | -38.78% |
| 2003-12-31 | S$1.75 B | 2.14% |
| 2002-12-31 | S$1.71 B | 350.89% |
| 2001-12-31 | S$0.38 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | S$15.63 M | -99.95% | 🇺🇸 USA |
 OPKO Health
OPK | S$1.05 B | -96.94% | 🇺🇸 USA |